ADRENACLICK Drug Patent Profile
✉ Email this page to a colleague
When do Adrenaclick patents expire, and what generic alternatives are available?
Adrenaclick is a drug marketed by Impax and is included in one NDA.
The generic ingredient in ADRENACLICK is epinephrine. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adrenaclick
A generic version of ADRENACLICK was approved as epinephrine by BPI LABS on July 29th, 2014.
Summary for ADRENACLICK
Recent Clinical Trials for ADRENACLICK
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Arthroplasty Foundation, Inc. | Phase 4 |
University of Louisville | Phase 4 |
NYU Langone Health | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for ADRENACLICK
US Patents and Regulatory Information for ADRENACLICK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax | ADRENACLICK | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-003 | Nov 25, 2009 | BX | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Impax | ADRENACLICK | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-004 | Nov 25, 2009 | BX | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADRENACLICK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Impax | ADRENACLICK | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-003 | Nov 25, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Impax | ADRENACLICK | epinephrine | INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS | 020800-004 | Nov 25, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ADRENACLICK
See the table below for patents covering ADRENACLICK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1824560 | PROCEDE ET DISPOSITIF DE DELIVRANCE D'EPINEPHRINE (METHOD AND APPARATUS FOR DELIVERING EPINEPHRINE) | ⤷ Try a Trial |
Russian Federation | 2431505 | УСТРОЙСТВО ДЛЯ ИНЪЕКЦИИ ЛЕКАРСТВ (ВАРИАНТЫ) И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ (DEVICE FOR DRUG INJECTION (VERSIONS) AND METHODS OF APPLICATION THEREOF) | ⤷ Try a Trial |
Australia | 683901 | ⤷ Try a Trial | |
European Patent Office | 1904145 | PROCEDE ET APPAREIL DE DELIVRANCE D'EPINEPHRINE (METHOD AND APPARATUS FOR DELIVERING EPINEPHRINE) | ⤷ Try a Trial |
Australia | 1994295 | ⤷ Try a Trial | |
Norway | 20073489 | ⤷ Try a Trial | |
Taiwan | 200727928 | Method and apparatus for delivering epinephrine | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |